Persistent Asset Partners »

Eupraxia Pharmaceuticals shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $275k 38k 7.24

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Balyasny Asset Management
Vivo Capital
Scotia Capital
Dr. Jeffrey R. Jay, M.D.
UBS Group
Point72 Asset Management
Ikarian Capital
Ally Bridge Group
Velan Capital Investment Management
Aisling Capital Management
Affinity Asset Advisors
Arrowstreet Capital, Limited Partnership
SummitTX Capital
Marshall Wace

View all funds holding Eupraxia Pharmaceuticals